Flublok or Fluzone With Advax-CpG55.2 or AF03
Clinical trial NCT03945825 · COMPLETED
Trial details
- NCT number
- NCT03945825
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-10
- Primary completion
- 2020-09-18
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.